Sugi Predict

Sugi Predict / Compounds / SCHEMBL6263201

SCHEMBL6263201

SCHEMBL6263201

CC(C(=O)O)N1c2ccccc2Oc2c(C(=O)O)cccc21

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ P2RX4 Q99571 9/20 0.44
▸ KDM4E B2RXH2 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ CASP7 P55210 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ ALOX5 P09917 1/20 0.40
▸ CYP2C9 P11712 1/20 0.39
▸ P2RX1 P51575 2/20 0.38
▸ MYC P01106 4/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ NR4A1 P22736 1/20 0.38
▸ P2RX3 P56373 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL179726 0.87 P2RX4 (0.56) P2RX4KDM4EGAACASP1CASP7
SCHEMBL10555490 0.85 P2RX4 (0.43) P2RX4KDM4EALOX5CYP2C9P2RX1
SCHEMBL10556539 0.76 P2RX4 (0.44) P2RX4P2RX1P2RX3MAPTSMN1; SMN2
SCHEMBL10560996 0.76 ALDH1A1 (0.41) P2RX4KDM4EKMT2AALOX5MYC
SCHEMBL10559583 0.76 P2RX4 (0.44) P2RX4KDM4EALOX5CYP2C9P2RX1
SCHEMBL994533 0.74 KMT2A (0.53) P2RX4KDM4EGAACASP1CASP7
SCHEMBL10560430 0.74 P2RX4 (0.41) P2RX4KDM4EP2RX1ALDH1A1P2RX3
SCHEMBL10559288 0.74 TRPA1 (0.46) P2RX4KDM4EALOX5MYCALDH1A1
SCHEMBL6445212 0.72 CYP2C9 (0.53) KDM4EALOX5CYP2C9MYCALDH1A1
Phenoxathiine SCHEMBL27584750 0.72 BCHE (0.47) P2RX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0707637-B1 ENHANCEMENT OF LACCASE REACTIONS NOVOZYMES AS (DK) 2005-11-02 — — EP claimed
US-20040049859-A1 Enzyme composition for bleaching human keratinous fibres and bleaching method L'OREAL S.A. (FR) 2004-03-18 — — US claimed
US-20040025265-A1 Enzyme composition for bleaching human keratinous fibres and bleaching method LANG GERARD (FR) 2004-02-12 — — US claimed
US-20030159706-A1 Enzyme composition for bleaching human keratinous fibres and bleaching method L'OREAL S.A. (FR) 2003-08-28 — — US claimed
US-20020119136-A1 Antimicrobial peroxidase compositions NOVOZYMES A/S (DK) 2002-08-29 — — US claimed
JP-2000512267-A — — 2000-09-19 — — JP claimed
EP-0975832-A1 ENZYMATIC DISCHARGE PRINTING OF DYED TEXTILES Novo Nordisk Biochem North America, Inc. (US) 2000-02-02 — — EP claimed
US-5965510-A USING AGENT COMPRISING AN ORGANIC CHEMICAL COMPOUND CONSISTING OF AT LEAST TWO AROMATIC RINGS, OF WHICH AROMATIC RINGS AT LEAST ONE RING IS SUBSTITUTED WITH NITROGEN AND OXYGEN OR SULFUR; WASHING, BLEACHING NOVO NORDISK A/S (DK) 1999-10-12 — — US claimed
US-5951714-A Enzymatic discharge printing of dyed textiles NOVO NORDISK BIOCHEM NORTH AMERICA, INC. (US) 1999-09-14 — — US claimed
EP-0912097-A1 ANTIMICROBIAL PEROXIDASE COMPOSITIONS NOVO NORDISK A/S (DK) 1999-05-06 — — EP claimed
US-5885304-A AROMATIC COMPOUNDS CONTAINING AT LEAST TWO RINGS, AT LEAST ONE SUBSTITUTED WITH NITROGEN OXYGEN, OR SULFUR NOVO NORDISK A/S (DK) 1999-03-23 — — US claimed
WO-1998046820-A1 ENZYMATIC DISCHARGE PRINTING OF DYED TEXTILES NOVO NORDISK BIOCHEM NORTH AMERICA, INC. (US) 1998-10-22 — — WO claimed
US-5795855-A DETERGENTS NOVO NORDISK A/S 1998-08-18 — — US claimed
WO-1997042825-A1 ANTIMICROBIAL PEROXIDASE COMPOSITIONS NOVO NORDISK A/S (DK) 1997-11-20 — — WO claimed
EP-0707637-A1 ENHANCEMENT OF LACCASE REACTIONS NOVO NORDISK A/S (DK) 1996-04-24 — — EP claimed
EP-0679183-A1 ENHANCEMENT OF ENZYME REACTIONS NOVO NORDISK A/S (DK) 1995-11-02 — — EP claimed
WO-1995001426-A1 ENHANCEMENT OF LACCASE REACTIONS NOVO NORDISK A/S (DK) 1995-01-12 — — WO claimed
EP-0707637-B1 ENHANCEMENT OF LACCASE REACTIONS NOVOZYMES AS (DK) 2005-11-02 — — EP disclosed
WO-1995001426-A1 ENHANCEMENT OF LACCASE REACTIONS NOVO NORDISK A/S (DK) 1995-01-12 — — WO disclosed
WO-1994012621-A1 ENHANCEMENT OF ENZYME REACTIONS NOVO NORDISK (DK) 1994-06-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030159706-A1 Enzyme composition for bleaching human keratinous fibres and bleaching method KRT18, LPO, MPO P2RX4 3376/4885KDM4E 354/4885GAA 177/4885
US-20040025265-A1 Enzyme composition for bleaching human keratinous fibres and bleaching method KRT18, LPO, ALDH1A2 P2RX4 4155/4885KDM4E 498/4885GAA 650/4885
US-20040049859-A1 Enzyme composition for bleaching human keratinous fibres and bleaching method KRT18, COXFA4, LPO P2RX4 3353/4885KDM4E 403/4885GAA 494/4885
US-20020119136-A1 Antimicrobial peroxidase compositions LPO, MPO, GPX4 P2RX4 3934/4885KDM4E 2290/4885GAA 1190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.